QIAGEN NV EO -,01 | 44.930 / +0.29% |
Date/Time | 01/22 / 17:00 |
Chg. / Chg.(%) | 0.130 / +0.29% |
Bid | 44.920 / 392 |
Ask | 44.940 / 375 |
Open | 44.510 |
Previous Close | 44.800 |
High | 45.010 |
Low | 44.290 |
Volume [EUR] | 12,802,990.470 |
Volume [Units] | 286,671 |
Price fixings | 2567 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 44.930 | ![]() |
286,671 |
Turquoise | 44.89 | ![]() |
149,650 |
NYSE | 54.65 | ![]() |
136,521 |
Cboe Europe .. | 44.92 | ![]() |
102,073 |
London Inter.. | 44.89 | ![]() |
37,961 |
Frankfurt | 44.9500 | ![]() |
12,675 |
TradeGate | 44.89 | ![]() |
10,405 |
Cboe US | 54.68 | ![]() |
6,109 |
IEX | 54.67 | ![]() |
1,606 |
Stuttgart | 44.840 | ![]() |
738 |
Hamburg | 44.620 | ![]() |
518 |
gettex | 44.920 | ![]() |
320 |
Cboe Europe .. | 44.64 | ![]() |
200 |
Düsseldorf | 44.920 | ![]() |
179 |
Cboe Europe .. | 44.87 | ![]() |
71 |
Vienna Globa.. | 44.75 | ![]() |
0 |
München | 44.470 | ![]() |
0 |
Hannover | 44.270 | ![]() |
0 |
Berlin | 44.330 | ![]() |
0 |
Lang & Schwa.. | 44.890 | ![]() |
|
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire